期刊文献+

白细胞介素17A在哮喘发病机制中的研究进展 被引量:4

下载PDF
导出
出处 《中国呼吸与危重监护杂志》 CAS 2009年第2期199-201,共3页 Chinese Journal of Respiratory and Critical Care Medicine
  • 相关文献

参考文献3

二级参考文献28

  • 1孙永昌.中性粒细胞在重症支气管哮喘患者气道炎症和气道重塑中的可能作用[J].中华结核和呼吸杂志,2004,27(12):853-855. 被引量:11
  • 2闫伯强,唐学义.哮喘患者Thl/Th2变化及布地奈德对其影响的研究[J].医药论坛杂志,2005,26(16):54-54. 被引量:11
  • 3王莉,王志强.IL-17与气道重塑[J].实用诊断与治疗杂志,2006,20(2):122-124. 被引量:7
  • 4吴彬,俞建,王莹,杨毅,时毓民,汪永红.哮喘缓解期患儿Th1/Th2相关上游转录因子及细胞因子的表达[J].实用儿科临床杂志,2006,21(21):1461-1462. 被引量:12
  • 5Djukanovic R, Homeyard S, Gratziou C, et al. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation. Am J Respir Crit Care Med,1997,155:826-832.
  • 6Oda N, Canelos PB, Essayan DM, et al. Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. Am J Respir Crit Care Med,2005,171:12-18.
  • 7Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol, 2001,108:430-438.
  • 8Barczyk A, Pierzchala W, Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med,2003,97:726-733.
  • 9Chakir J,Shannon J, Molet S, et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type Ⅰ and type Ⅲ collagen expression. J Allergy Clin Immunol, 2003,111:1293-1298.
  • 10Cundall M, Sun Y, Miranda C, et al. Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. J Allergy Clin Immunol, 2003,112:1064-1071.

共引文献36

同被引文献38

  • 1陈军浩,吴超,欧阳建,刘勇,顾光煜.CpG-ODN2216刺激健康人外周血淋巴细胞T_H1/T_H2细胞因子的表达[J].临床检验杂志,2007,25(3):192-193. 被引量:4
  • 2张晓岩,林江涛.支气管哮喘的流行病学及发病危险因素[J].中华结核和呼吸杂志,2007,30(7):538-541. 被引量:48
  • 3莫碧文,张珍祥,徐永健,王昌明,熊维宁,刘先胜,房春生.核因子-κB对TNF-α诱导的大鼠气道平滑肌细胞增殖、凋亡及TGF-β_1表达的影响[J].中国病理生理杂志,2007,23(9):1767-1771. 被引量:5
  • 4Maddur MS,Miossec P,Kaveri SV,et al. Thl7 cells: biology, patho- genesis of autoimmune and intlammatory diseases, and therapeutic strategies[J]. Am J Pathol,2012,181 ( 1 ) :8 - 18.
  • 5Yu Hu, Dao - xin Ma, Ning - ning Shan. Increased Number of Tcl7 and Correlation with Thl7 Ceils in Patients with Immune Thrombocyto- penia[J]. PLos ONE,2011,6(10) : e26522.
  • 6Saxena A, Desbois S, Carri: N, et al. Tcl7 CD8 + T cells potentiate Thl -mediated autoimmune diabetes in a mouse model [ J ]. J Immu- nol, 2012 189(6) :3140 -3149.
  • 7Sakaguchi S, Sakagllm N, Asano M, et al. Immunologic self - tolerance maintained by activated T cells expressing IL -2 receptor alphachains ( CD25 ). Breakdown of a single mechanism of self - tolerance causes various autoimmune diseases [ J ]. J Immunol, 1995,155 ( 3 ) : 1115 - 1164.
  • 8Harrington LE, Hatton RD, Mangan PR, et al. (2005) Interleukin 17 -producing CIM( + ) effector T ceils develop via a lineage dis- tinct from the T helper type 1 and 2 lineages [ J ]. Nat Immunol, 2005, 6(11) : 1123 - 1132.
  • 9Wong CK, Lun SW, Ko FW, et al. Activation of peripheral Thl7 lymphocytes in patients with asthma [ J ]. Immunol Invest, 2009,38 (7) : 652 -664.
  • 10Huber M, Heink S, Grothe H, et al. (2009) A Thl7 -like develop- mental process leads to CD8 + Tcl7 cells with reduced cytotoxic ac- tivity[J]. Eur J Immunol, 2009,39(7) : 1716 - 1725.

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部